Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
OrthoPediatrics management to virtually meet with JMP Securities » 04:55
05/21/20
05/21
04:55
05/21/20
04:55
KIDS

OrthoPediatrics

$46.69 /

+0.04 (+0.09%)

Virtual Meeting to be…

Virtual Meeting to be held on May 21 hosted by JMP Securities.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$46.69 /

+0.04 (+0.09%)

KIDS OrthoPediatrics
$46.69 /

+0.04 (+0.09%)

05/06/20 Piper Sandler
OrthoPediatrics trends in April not as bad as feared, says Piper Sandler
03/30/20 Piper Sandler
OrthoPediatrics will bounce back well post COVID-19, says Piper Sandler
03/05/20 Piper Sandler
Piper continues to recommend OrthoPediatrics after Q4 results
01/13/20 Piper Sandler
OrthoPediatrics momentum can carry into 2020, says Piper Sandler
KIDS OrthoPediatrics
$46.69 /

+0.04 (+0.09%)

Conference/Events
OrthoPediatrics management to virtually meet with JMP Securities » 11:47
05/20/20
05/20
11:47
05/20/20
11:47
KIDS

OrthoPediatrics

$47.97 /

+1.32 (+2.83%)

Virtual Meeting to be…

Virtual Meeting to be held on May 21 hosted by JMP Securities.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$47.97 /

+1.32 (+2.83%)

KIDS OrthoPediatrics
$47.97 /

+1.32 (+2.83%)

05/06/20 Piper Sandler
OrthoPediatrics trends in April not as bad as feared, says Piper Sandler
03/30/20 Piper Sandler
OrthoPediatrics will bounce back well post COVID-19, says Piper Sandler
03/05/20 Piper Sandler
Piper continues to recommend OrthoPediatrics after Q4 results
01/13/20 Piper Sandler
OrthoPediatrics momentum can carry into 2020, says Piper Sandler
KIDS OrthoPediatrics
$47.97 /

+1.32 (+2.83%)

Recommendations
OrthoPediatrics trends in April not as bad as feared, says Piper Sandler » 15:47
05/06/20
05/06
15:47
05/06/20
15:47
KIDS

OrthoPediatrics

$44.45 /

-2.03 (-4.37%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien said OrthoPediatrics saw considerable declines in April of about 60%, but he said those trends were not as bad as feared. The company also said it is seeing a slight improvement in May as elective procedures begin to resume, added O'Brien, who thinks "that the necessary pieces are in place" for OrthoPediatrics to bounce back fairly quickly once the pandemic impact recedes. The analyst, who views the company as well-positioned to capitalize on market opportunities once elective volumes begin to normalize, keeps an Overweight rating on the shares.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$44.45 /

-2.03 (-4.37%)

03/30/20 Piper Sandler
OrthoPediatrics will bounce back well post COVID-19, says Piper Sandler
03/05/20 Piper Sandler
Piper continues to recommend OrthoPediatrics after Q4 results
01/13/20 Piper Sandler
OrthoPediatrics momentum can carry into 2020, says Piper Sandler
01/07/20 SunTrust
OrthoPediatrics initiated with a Buy at SunTrust
Over a month ago
Hot Stocks
OrthoPediatrics suspends FY20 guidance due to COVID-19 » 16:31
05/05/20
05/05
16:31
05/05/20
16:31
KIDS

OrthoPediatrics

$46.50 /

+3.52 (+8.19%)

Due to the rapidly…

Due to the rapidly evolving environment and continued uncertainties surrounding the duration and impact of COVID-19, OrthoPediatrics maintains suspension of its revenue growth and set consignment guidance for the full year 2020.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$46.50 /

+3.52 (+8.19%)

03/30/20 Piper Sandler
OrthoPediatrics will bounce back well post COVID-19, says Piper Sandler
03/05/20 Piper Sandler
Piper continues to recommend OrthoPediatrics after Q4 results
01/13/20 Piper Sandler
OrthoPediatrics momentum can carry into 2020, says Piper Sandler
01/07/20 SunTrust
OrthoPediatrics initiated with a Buy at SunTrust
Earnings
OrthoPediatrics reports Q1 EPS (30c), consensus (25c) » 16:30
05/05/20
05/05
16:30
05/05/20
16:30
KIDS

OrthoPediatrics

$46.50 /

+3.52 (+8.19%)

Reports Q1 revenue…

Reports Q1 revenue $16.4M, consensus $17.04M.Mark Throdahl, President and Chief Executive Officer of OrthoPediatrics, commented, "First, we would like to thank our colleagues and the entire healthcare community for their dedication addressing the global COVID-19 pandemic. The extraordinary effort displayed by our team at this time as we continue to execute against our strategic initiatives is a testament to our Company's culture, which is the foundation of all our success. We saw a strong start to the year with 30% domestic revenue growth for the quarter, and we are pleased to sustain our momentum on corporate initiatives that will allow us to emerge from the COVID-19 crisis stronger than when we entered it."

ShowHide Related Items >><<
KIDS OrthoPediatrics
$46.50 /

+3.52 (+8.19%)

03/30/20 Piper Sandler
OrthoPediatrics will bounce back well post COVID-19, says Piper Sandler
03/05/20 Piper Sandler
Piper continues to recommend OrthoPediatrics after Q4 results
01/13/20 Piper Sandler
OrthoPediatrics momentum can carry into 2020, says Piper Sandler
01/07/20 SunTrust
OrthoPediatrics initiated with a Buy at SunTrust
Conference/Events
OrthoPediatrics to host conference call » 08:25
04/02/20
04/02
08:25
04/02/20
08:25
KIDS

OrthoPediatrics

$37.64 /

-2.02 (-5.09%)

Conference call to…

Conference call to discuss the acquisition of ApiFix with FDA approved Non-Fusion Scoliosis Technology will be held on April 2 at 8:30 am. Webcast Link

ShowHide Related Items >><<
KIDS OrthoPediatrics
$37.64 /

-2.02 (-5.09%)

03/30/20 Piper Sandler
OrthoPediatrics will bounce back well post COVID-19, says Piper Sandler
03/05/20 Piper Sandler
Piper continues to recommend OrthoPediatrics after Q4 results
01/13/20 Piper Sandler
OrthoPediatrics momentum can carry into 2020, says Piper Sandler
01/07/20 SunTrust
OrthoPediatrics initiated with a Buy at SunTrust
Conference/Events
OrthoPediatrics to host conference call » 04:55
04/02/20
04/02
04:55
04/02/20
04:55
KIDS

OrthoPediatrics

$37.64 /

-2.02 (-5.09%)

Conference call to…

Conference call to discuss the acquisition of ApiFix with FDA approved Non-Fusion Scoliosis Technology will be held on April 2 at 8:30 am. Webcast Link

ShowHide Related Items >><<
KIDS OrthoPediatrics
$37.64 /

-2.02 (-5.09%)

03/30/20 Piper Sandler
OrthoPediatrics will bounce back well post COVID-19, says Piper Sandler
03/05/20 Piper Sandler
Piper continues to recommend OrthoPediatrics after Q4 results
01/13/20 Piper Sandler
OrthoPediatrics momentum can carry into 2020, says Piper Sandler
01/07/20 SunTrust
OrthoPediatrics initiated with a Buy at SunTrust
Conference/Events
OrthoPediatrics to host conference call » 17:04
04/01/20
04/01
17:04
04/01/20
17:04
KIDS

OrthoPediatrics

$37.64 /

-2.02 (-5.09%)

Conference call to…

Conference call to discuss the acquisition of ApiFix with FDA approved Non-Fusion Scoliosis Technology will be held on April 2 at 8:30 am. Webcast Link

ShowHide Related Items >><<
KIDS OrthoPediatrics
$37.64 /

-2.02 (-5.09%)

03/30/20 Piper Sandler
OrthoPediatrics will bounce back well post COVID-19, says Piper Sandler
03/05/20 Piper Sandler
Piper continues to recommend OrthoPediatrics after Q4 results
01/13/20 Piper Sandler
OrthoPediatrics momentum can carry into 2020, says Piper Sandler
01/07/20 SunTrust
OrthoPediatrics initiated with a Buy at SunTrust
Hot Stocks
OrthoPediatrics acquires ApiFix in cash, stock transaction » 16:09
04/01/20
04/01
16:09
04/01/20
16:09
KIDS

OrthoPediatrics

$38.28 /

-1.38 (-3.48%)

OrthoPediatrics announced…

OrthoPediatrics announced that it has acquired ApiFix, including its minimally invasive deformity correction, or MID-C, system for non-fusion treatment of progressive adolescent idiopathic scoliosis, or AIS, for 934,768 shares of OrthoPediatrics common stock and $2M in cash paid at closing, plus milestone payments and an earnout over a period of four years. ApiFix is an Israel and Boston, Massachusetts based medical device company with a less invasive spinal deformity correction system for non-fusion treatment of progressive AIS. Together with vertebral body tethering, it is one of only two non-fusion technologies approved by the FDA under its Humanitarian Device Exemption provision. The MID-C system is approved for use in adolescent patients with Lenke type 1 and Lenke type 5 curves of 40 degrees to 60 degrees and acts as an internal brace implanted unilaterally on the concave aspect of the curvature. It becomes OrthoPediatrics' 35th surgical system. ApiFix's technology is supported by intellectual property protection, including 46 U.S. and International patents granted and 25 patent applications. The company is led by Paul Mraz, a Boston-based executive with nearly 30 years of spine and orthopedic medical device experience. Mraz and the entire ApiFix team have joined OrthoPediatrics post-acquisition.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$38.28 /

-1.38 (-3.48%)

03/30/20 Piper Sandler
OrthoPediatrics will bounce back well post COVID-19, says Piper Sandler
03/05/20 Piper Sandler
Piper continues to recommend OrthoPediatrics after Q4 results
01/13/20 Piper Sandler
OrthoPediatrics momentum can carry into 2020, says Piper Sandler
01/07/20 SunTrust
OrthoPediatrics initiated with a Buy at SunTrust
Hot Stocks
OrthoPediatrics receives FDA 510(k) clearance, expanded indications for RESPONSE » 09:08
03/31/20
03/31
09:08
03/31/20
09:08
KIDS

OrthoPediatrics

$40.28 /

+4.08 (+11.27%)

OrthoPediatrics announced…

OrthoPediatrics announced it has received 510(k) clearance from the U.S. Food and Drug Administration to expand the indications for its RESPONSE Scoliosis System to include neuromuscular implants. This 510(k) clearance represents a significant milestone in the Company's development toward its next generation RESPONSE Scoliosis System, RESPONSE NeuroMuscular.This new system will be entirely dedicated to the treatment of neuromuscular scoliosis in pediatrics and builds on existing product offerings focused on treating this unique class of patients. The system is being developed in conjunction with pediatric orthopedic surgeons to address the distinct challenges in treating the neuromuscular scoliosis population. Building on the base of the Company's RESPONSE(TM) Spine System, RESPONSE - NM will feature a complete set of implants and instruments with unique attributes that simplify insertion and specific options to address extreme hyperlordosis.

ShowHide Related Items >><<
KIDS OrthoPediatrics
$40.28 /

+4.08 (+11.27%)

03/30/20 Piper Sandler
OrthoPediatrics will bounce back well post COVID-19, says Piper Sandler
03/05/20 Piper Sandler
Piper continues to recommend OrthoPediatrics after Q4 results
01/13/20 Piper Sandler
OrthoPediatrics momentum can carry into 2020, says Piper Sandler
01/07/20 SunTrust
OrthoPediatrics initiated with a Buy at SunTrust

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.